MarketPeel
Insider Trading Intelligence
SW

Sarah Joanne Williams

ANTX
PRINCIPAL ACCOUNTING OFFICER · AN2 THERAPEUTICS, INC. · CIK 0002108922
FILING MIX · LIFETIME33%/67%
BUYS
1
SELLS
2
TOTAL VALUE
$1.5K
COMPANIES
1
ACTIVE SINCE
Feb 2026
HOLDINGS NOW
66,583
AVG SELL PX
$2.57
TRADE KIND
SHOWING 3 / 3
Trades · vs SPY
Loading price series…
Performance · forward returns vs SPY
1 backtested trades · 8 horizons · 3 pending
Forward-return performance of every backtestable P/S trade by Sarah Joanne Williams, measured at 8 horizons from 7 days to 2 years. Deduped per economic event so co-filings count once. Excess return = trade return minus SPY return over the same window.
HORIZONTRADESWIN RATEINSIDER RETURNSPY RETURNMEAN EXCESSMEDIAN EXCESST-STAT
7d1+0.00%+415.09%-0.46%+415.56%+415.56%
14d1+0.00%+371.70%-1.40%+373.10%+373.10%
30d1+0.00%+208.49%-3.60%+212.09%+212.09%
60d1+0.00%+341.51%+5.93%+335.58%+335.58%
90d1+0.00%+308.49%
180d1(1 pending)
1y1(1 pending)
2y1(1 pending)
How to read this: Insider Returnis the average raw return of the filer's trades over the horizon. SPY Return is what SPY did over those same windows — reference only, not a comparison. The headline alpha number is Mean Excess = Insider − SPY; green means the filer beat SPY, red means they trailed it. Win rate is the share of individual trades where the filer beat SPY. T-statvalues above 2 mean the alpha is unlikely to be chance given the sample size. "Pending" counts trades where the horizon hasn't elapsed yet; their stats are not included in the row average.
Holdings over time
ANTX · 66,583 shares · as of May 29, 2026
016,79433,58850,38167,175SHARES HELD
Trading cadence · quarterly flow
BUY SELL
2026
2026
FLOW · 1 buys / 2 sellsCOVERAGE · 2 quarters
Form 4 filings · all activity
COMPANYTYPESHARESPRICEVALUEHELD AFTERTRADE DATEFILEDDETAILS
ANTX
AN2 THERAPEUTICS, INC.
SALE
Principal Accounting Officer
265$4.43$1.2K66,583May 29, 2026Jun 2, 2026View →
ANTX
AN2 THERAPEUTICS, INC.
SALE
Principal Accounting Officer
327$1.06$34766,848Mar 3, 2026Mar 5, 2026View →
ANTX
AN2 THERAPEUTICS, INC.
PURCHASEGRANT
Stock grant
48,37567,175Feb 20, 2026Feb 23, 2026View →
Other insiders · ANTX
Loading peer insiders…
About this filer
CIK 0002108922
ROLE
Principal Accounting Officer
PRIMARY
ANTX
COMPANIES
1
ACTIVE SINCE
Feb 2026
MARKETPEEL · /INSIDER/0002108922DATA · SEC EDGAR · FORM 4 · CONSOLIDATED TAPE
FREE · DAILY · 6 AM ET

One short email. Insider buys, congressional trades, and plain-English analysis.

Feedback